Omics CRO Services Global Market Opportunities And Strategies To 2034
상품코드:1948191
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 420 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
세계의 오믹스 CRO 서비스 시장은 2024년에 약 342억 994만 달러 규모에 달하고, 2019년 이후 13.55%의 CAGR로 성장해왔습니다. 이 시장은 2024년 342억 9,494만 달러에서 2029년 616억 2,889만 달러로 12.49%의 성장률로 확대될 것으로 예측됩니다. 이후 2029년 이후에도 CAGR 10.77%로 성장하여 2034년에는 1,027억 9,404만 달러에 달할 것으로 예상됩니다.
오믹스 CRO(수탁연구기관) 서비스란, 유전체학, 전사체학, 단백질체학, 대사체학, 후생유전체학 등의 분야의 대규모 생물학적 데이터 분석을 전문으로 하는 외부 위탁 연구 솔루션을 가리킵니다. 이러한 서비스는 샘플 처리, 하이 스루풋 데이터 생성, 바이오인포매틱스 해석, 해석을 포함한 종합적인 서포트를 제공하고, 의약품, 바이오테크놀러지, 맞춤형 의료의 연구개발을 신속화합니다. 오믹스 CRO 서비스의 주요 목적은 조직이 복잡하고 대량 오믹스 연구를, 자사 인프라에의 막대한 투자를 수반하지 않고 효율적으로 실시할 수 있도록 하는 것입니다.
오믹스 CRO 서비스 시장은 신약개발, 정밀의료, 바이오마커 식별을 위해 다양한 기술을 적용한 외주 연구 및 분석 서비스를 조직, 개인사업자 또는 파트너십 등의 사업체가 판매하는 시장으로 구성되어 있습니다.
정부의 유리한 정책
과거에는 정부의 우호적인 정책이 오믹스 CRO 서비스 시장의 성장을 뒷받침했습니다. 정밀의료에 대한 자금 지원 확대, 유전체 연구 보조금, 지원적인 규제 프레임워크와 같은 유리한 정부 정책은 고급 시퀀싱, 바이오마커 발견, 멀티오믹스 능력의 확장을 가능하게함으로써 오믹스 CRO 서비스를 지원합니다. 이러한 정책은 CRO의 재정적, 운영적 장벽을 낮추고 혁신과 첨단 기술 채택을 촉진합니다. 또한, 임상시험 및 데이터 공유를 위한 정부 지원 프로그램은 연구 협력과 세계 서비스 개발을 가속화합니다. 예를 들어, 2023년 9월 미국 정부 기관인 국립보건원(NIH)은 다양한 집단의 건강과 질병을 조사하기 위해 다양한 오믹스 데이터 유형의 통합에 초점을 맞춘 멀티오믹스 연구를 추진하기 위해 초기 자금 5,030만 달러를 투자한 컨소시엄을 설립했습니다. 설립하였습니다. 이러한 노력은 멀티오믹스 서비스를 전문으로 하는 CRO에게 기회를 제공하고 있습니다. 따라서 유리한 정부 정책이 오믹스 CRO 서비스 시장의 성장을 견인한 것입니다.
기술 통합 강화를 위한 전략적 제휴
오믹스 CRO 서비스 시장에서 사업을 전개하는 주요 기업들은 기술 통합 강화와 시장 확대를 위해 전략적 파트너십을 구축하고 있습니다. 전략적 파트너십은 일반적으로 두 개 이상의 조직이 자원, 전문지식, 노력을 결합하여 공동의 목표를 달성하기 위해 협력하는 관계를 말합니다. 예를 들어, 2024년 11월에는 통합 전임상, 임상, 분석 서비스를 제공하는 미국 소재 CRO(임상시험수탁기관)인 Frontage Laboratories와 폴란드 소재의 임상 및 진단 서비스 제공업체인 Medicover Integrated Clinical Services(MICS)와 제휴하였습니다. 이번 전략적 제휴는 프론티지의 임상시험 서비스와 메디커버의 첨단 유전체 검사 솔루션을 통합하는 것을 목표로 하고 있습니다. 메디커버는 13개국에 100개 이상의 연구소를 운영하며 차세대 염기서열분석(NGS), 분자병리학, 약리유전체학 등 종합적인 유전체 분석 서비스를 제공하고 있습니다.
세계 오믹스 CRO 서비스 시장은 주요 기업들이 시장을 독점하는 비교적 집중적인 구조로 되어 있습니다. 2024년 기준, 시장 상위 10개사의 점유율은 전체의 15.12%를 차지하고 있습니다.
목차
제1장 주요 요약
제2장 목차
제3장 표목차
제4장 그림목차
제5장 보고서 구성
제6장 시장 특징
제7장 주요 시장 동향
제8장 세계의 오믹스 CRO 서비스 성장 분석 및 전략적 분석 프레임워크
제9장 세계의 오믹스 CRO 서비스 시장 : 세분화
제10장 중국 시장
제11장 일본 시장
제12장 유럽 시장
제13장 미국 시장
제14장 캐나다 시장
제15장 세계의 경쟁 구도와 기업 개요
제16장 기타 주요 기업과 혁신적 기업
제17장 세계의 탑 10 기업 강점과 약점에 관한 정보
제18장 세계의 탑 10 기업 AI/ML능력에 관한 정보
제19장 세계의 탑 10 기업에 의한 혁신에 관한 정보(혁신 종류를 포함한 설명)
제20장 단백질체학, 대사체학, 리포미크스프랏트포무/프로젝트 용으로, 세계의 탑 10 기업이 특별히 채용하고 있는 기술에 관한 정보
제21장 세계의 탑 10 기업의 종합적인 능력과 기술에 관한 정보(커버리지, 다이나믹 레인지, 민감도, 재현성을 포함)
제22장 주요 기업 리스트 오믹스 CRO 서비스 시장
제23장 유럽의 경쟁 구도와 기업 개요
제24장 영국의 경쟁 구도와 기업 개요
제25장 독일의 경쟁 구도와 기업 개요
제26장 미국의 경쟁 구도와 기업 개요
제27장 일본의 경쟁 구도와 기업 개요
제28장 주요 오믹스 CRO 서비스 기업 리스트(국가별)
제29장 오믹스 CRO 서비스 시장의 기술 플랫폼에서의 AI/ML 현재 활용 상황
제30장 주요 고객 기업 리스트
제31장 상대적인 수요/서비스 규모
제32장 오믹스 CRO 프로젝트의 의사결정에의 AI/ML활용 빈도
제33장 오믹스 CRO 서비스 시장 미충족 요구
제34장 오믹스 CRO 서비스 시장의 기회와 위협
제35장 오믹스 CRO 서비스 시장의 기술 변화
제36장 경쟁하기 위해서 필요한 전문 지식
제37장 오믹스 CRO 서비스 시장의 소규모 사업자
제38장 경쟁 벤치마킹
제39장 경쟁 대시보드
제40장 주요 인수합병
제41장 최근 동향 오믹스 CRO 서비스 시장
제42장 기회와 전략
제43장 오믹스 CRO 서비스 시장 : 결론과 제안
제44장 부록
KSM
영문 목차
영문목차
Omics CRO (Contract Research Organization) services refer to outsourced research solutions specializing in large-scale biological data analysis in fields such as genomics, transcriptomics, proteomics, metabolomics, and epigenomics. These services offer comprehensive support, encompassing sample processing, high-throughput data generation, bioinformatics analysis, and interpretation, to expedite research and development in pharmaceuticals, biotechnology, and personalized medicine. The primary purpose of omics CRO services is to enable organizations to conduct complex, high-volume omics studies efficiently without incurring significant investment in in-house infrastructure.
The omics CRO services market consists of sales, by entities (organizations, sole traders, or partnerships) of outsourced research and analytical services that apply different technologies for drug discovery, precision medicine, and biomarker identification.
The global omics CRO services market reached a value of nearly $34,209.94 million in 2024, having grown at a compound annual growth rate (CAGR) of 13.55% since 2019. The market is expected to grow from $34,209.94 million in 2024 to $61,628.89 million in 2029 at a rate of 12.49%. The market is then expected to grow at a CAGR of 10.77% from 2029 and reach $ 102,794.04 million in 2034.
Favorable Government Initiatives
During the historic period, the favorable government initiatives supported the growth of the omics CRO services market. Favorable government initiatives, such as increased funding for precision medicine, grants for genomics research, and supportive regulatory frameworks, help omics CRO services by enabling expansion of advanced sequencing, biomarker discovery, and multi-omics capabilities. These policies reduce financial and operational barriers for CROs, encouraging innovation and adoption of cutting-edge technologies. Additionally, government-backed programs for clinical trials and data sharing accelerate research collaborations and global service reach. For instance, in September 2023, the National Institutes of Health (NIH), a US-based government agency, established consortium with an initial funding of $50.3 million to advance multi-omics research, focusing on integrating various omics data types to study health and disease in diverse populations. This initiative provides opportunities for CROs specializing in multi-omics services. Therefore, the favorable government initiatives drove the growth of the omics CRO services market.
Strategic Collaborations To Enhance Technology Integration
Key companies operating in the omics CRO services market are adopting a strategic partnership approach to enhance technology integration and expand market reach. A strategic partnership typically refers to a collaborative relationship between two or more organizations where they combine their resources, expertise, and efforts to achieve common goals or objectives. For instance, in November 2024, Frontage Laboratories, US-based contract research organization (CRO) providing integrated preclinical, clinical, and analytical services, partnered with Medicover Integrated Clinical Services (MICS), a Poland-based clinical and diagnostic services provider, his strategic partnership aims to integrate Frontage's clinical trial services with Medicover's advanced genomic testing solutions. Medicover, operating over 100 laboratories across 13 countries, provides comprehensive genomic analysis services, including next-generation sequencing (NGS), molecular pathology, and pharmacogenomics.
The global omics CRO services market is fairly concentrated, with a large player operating in the market. The top ten competitors in the market made up to 15.12% of the total market in 2024.
Omics CRO Services Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global omics CRO services market as it emerges from the COVID-19 shut down.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 10 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Where is the largest and fastest-growing market for omics CRO services? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The omics CRO services market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider omics CRO services market; and compares it with other markets.
The report covers the following chapters
Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type of omics services, by technology platform, by application and by end-user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type of omics services, by technology platform, by application and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
Regional Market Size And Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Recent Developments- Information on recent developments in the market covered in the report.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations- This section includes recommendations for omics CRO services providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:
1) By Type Of Omics Services: Genomics; Transcriptomics; Proteomics; Metabolomics; Lipidomics; Multiomics; Single-Cell Omics; Other Type Of Omics Services
2) By Technology Platform: Next-Generation Sequencing (NGS); Microarray Technology; Mass Spectrometry; Chromatography; Bioinformatics Tools; Other Technology Platforms
3) By Application: Drug Discovery And Development; Diagnostics; Personalized Medicine; Other Applications
4) By End Users: Research And Academic Institutions; Pharmaceutical And Biotechnology Companies; Clinical And Diagnostic Laboratories
Companies Mentioned: Labcorp Holding Inc. (including Covance); Thermo Fisher Scientific Inc. (PPD); Charles River Laboratories International Inc.; Eurofins Scientific SE; BGI Genomics Co. Ltd.
8.7 Total Addressable Market for the Omics CRO Services Market
8.7.1 TAM Comparison Analysis
9 Global Omics CRO Services Market Segmentation
9.1 Global Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.2 Global Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.3 Global Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.4 Global Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
9.5 Global Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10 China Market
10.1 Market Overview
10.1.1 Country Information
10.1.2 Market Information
10.1.3 Background Information
10.1.4 Government Initiatives
10.1.5 Regulations
10.1.6 Regulatory Bodies
10.1.7 Major Associations
10.1.8 Taxes Levied
10.1.9 Corporate Tax Structure
10.1.10 Investments
10.1.11 Major Companies
10.2 China Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.3 China Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.4 China Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.5 China Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.6 China Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.7 India Market
10.8 India Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.9 India Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.10 India Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.11 India Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
10.12 India Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11 Japan Market
11.1 Market Overview
11.1.1 Country Information
11.1.2 Market Information
11.1.3 Background Information
11.1.4 Government Initiatives
11.1.5 Regulations
11.1.6 Regulatory Bodies
11.1.7 Major Associations
11.1.8 Taxes Levied
11.1.9 Corporate Tax Structure
11.1.10 Investments
11.1.11 Major Companies
11.2 Japan Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.3 Japan Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.4 Japan Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.5 Japan Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
11.6 Japan Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12 Europe Market
12.1 Market Overview
12.1.1 Region Information
12.1.2 Market Information
12.1.3 Background Information
12.1.4 Government Initiatives
12.1.5 Regulations
12.1.6 Regulatory Bodies
12.1.7 Major Associations
12.1.8 Taxes Levied
12.1.9 Corporate Tax Structure
12.1.10 Investments
12.1.11 Major Companies
12.2 Europe Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.3 Europe Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.4 Europe Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.5 Europe Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.6 Europe Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.7 Europe Omics CRO Services Market: Country Analysis
12.8 UK Market
12.9 UK Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.10 UK Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.11 UK Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.12 UK Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.13 UK Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.14 Germany Market
12.15 Germany Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.16 Germany Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.17 Germany Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.18 Germany Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.19 Germany Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.20 France Market
12.21 France Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.22 France Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.23 France Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.24 France Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.25 France Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.26 Italy Market
12.27 Italy Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.28 Italy Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.29 Italy Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.30 Italy Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.31 Italy Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.32 Spain Market
12.33 Spain Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.34 Spain Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.35 Spain Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.36 Spain Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.37 Spain Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.38 Rest Of Europe Market
12.39 Rest Of Europe Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.40 Rest Of Europe Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.41 Rest Of Europe Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.42 Rest Of Europe Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
12.43 Rest Of Europe Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13 USA Market
13.1 Market Overview
13.1.1 Country Information
13.1.2 Market Information
13.1.3 Background Information
13.1.4 Government Initiatives
13.1.5 Regulations
13.1.6 Regulatory Bodies
13.1.7 Major Associations
13.1.8 Taxes Levied
13.1.9 Corporate Tax Structure
13.1.10 Investments
13.1.11 Major Companies
13.2 USA Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.3 USA Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.4 USA Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.5 USA Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
13.6 USA Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14 Canada Market
14.1 Market Overview
14.1.1 Country Information
14.1.2 Market Information
14.1.3 Background Information
14.1.4 Government Initiatives
14.1.5 Regulations
14.1.6 Regulatory Bodies
14.1.7 Major Associations
14.1.8 Taxes Levied
14.1.9 Corporate Tax Structure
14.1.10 Investments
14.1.11 Major Companies
14.2 Canada Omics CRO Services Market, Segmentation By Type Of Omics Services, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.3 Canada Omics CRO Services Market, Segmentation By Technology Platform, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.4 Canada Omics CRO Services Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.5 Canada Omics CRO Services Market, Segmentation By End Users, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
14.6 Canada Omics CRO Services Market, Sub-Segmentation Of Drug Discovery And Development, By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
15 Global Competitive Landscape And Company Profiles
15.1 Company Profiles
15.2 Labcorp Holding Inc. (including Covance)
15.2.1 Company Overview
15.2.2 Products And Services
15.2.3 Financial Overview
15.3 Thermo Fisher Scientific Inc. (PPD)
15.3.1 Company Overview
15.3.2 Products And Services
15.3.3 Business Strategy
15.3.4 Financial Overview
15.4 Charles River Laboratories International Inc.
15.4.1 Company Overview
15.4.2 Products And Services
15.4.3 Financial Overview
15.5 Eurofins Scientific SE
15.5.1 Company Overview
15.5.2 Products And Services
15.5.3 Financial Overview
15.6 BGI Genomics Co. Ltd.
15.6.1 Company Overview
15.6.2 Products And Services
15.6.3 Financial Overview
16 Other Major And Innovative Companies
16.1 Novogene Co. Ltd.
16.1.1 Company Overview
16.1.2 Products And Services
16.2 GENEWIZ from Azenta
16.2.1 Company Overview
16.2.2 Products And Services
16.3 Frontage Laboratories
16.3.1 Company Overview
16.3.2 Products And Services
16.4 Somalogic Inc. (SomaScan(R))
16.4.1 Company Overview
16.4.2 Products And Services
16.5 Metabolon Inc.
16.5.1 Company Overview
16.5.2 Products And Services
17 Information On Strengths And Weaknesses Of Top 10 Global Companies
17.1 Labcorp Holding Inc. (including Covance)
17.1.1 Strengths
17.1.2 Weaknesses
17.2 Thermo Fisher Scientific Inc. (PPD)
17.2.1 Strengths
17.2.2 Weaknesses
17.3 Charles River Laboratories
17.3.1 Strengths
17.3.2 Weaknesses
17.4 Eurofins Scientific SE
17.4.1 Strengths
17.4.2 Weaknesses
17.5 BGI Genomics Co. Ltd.
17.5.1 Strengths
17.5.2 Weaknesses
17.6 Novogene Co. Ltd.
17.6.1 Strengths
17.6.2 Weaknesses
17.7 GENEWIZ from Azenta
17.7.1 Strengths
17.7.2 Weaknesses
17.8 Frontage Laboratories
17.8.1 Strengths
17.8.2 Weaknesses
17.9 Somalogic Inc. (SomaScan(R))
17.9.1 Strengths
17.9.2 Weaknesses
17.10 Metabolon Inc.
17.10.1 Strengths
17.10.2 Weaknesses
18 Information On AI/ML Capabilities Of Top 10 Global Companies
18.1 Labcorp Holding Inc. (Including Covance)
18.1.1 Bioinformatics And Genomics Pipelines (NGS, Expression, Multi-Omics)
18.1.2 Clinical and Real-World Data (RWD) with Predictive Analytics
18.1.3 Digital Pathology And Image-Based AI
18.1.4 Cloud Infrastructure and Generative-AI Clinician Tools
18.1.5 Partnerships And External AI/ML Collaborations
18.2 Thermo Fisher Scientific Inc. (PPD)
18.2.1 Accelerator(TM) Drug Development Platform
18.2.2 AI-Powered Clinical Trial Forecasting
18.2.3 PPD(TM) TrueCast AI Solution
18.2.4 Partnership with OpenAI
18.2.5 Integration of AI in Laboratory Services
18.3 Charles River Laboratories
18.3.1 Logica: AI-Powered Drug Discovery Platform
18.3.2 Collaborations with Aitia and Related Sciences
18.3.3 Integration of Omics and New Approach Methodologies
18.4 Eurofins Scientific SE
18.4.1 Eurofins DiscoveryAI: SAFIRE Platform
18.4.2 Eurofins Viracor Bioinformatics & AI Center of Excellence
